227 related articles for article (PubMed ID: 24962166)
1. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.
Tao YF; Xu LX; Lu J; Cao L; Li ZH; Hu SY; Wang NN; Du XJ; Sun LC; Zhao WL; Xiao PF; Fang F; Li YH; Li G; Zhao H; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
J Transl Med; 2014 Jun; 12():182. PubMed ID: 24962166
[TBL] [Abstract][Full Text] [Related]
2. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
4. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
5. tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Li ZH; Wang NN; Fang F; Xu LX; Pan J
Leuk Lymphoma; 2015; 56(10):2931-44. PubMed ID: 25629980
[TBL] [Abstract][Full Text] [Related]
6. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
7. Promoter of TFPI-2 is hypermethylated in Chinese pediatric acute myeloid leukemia.
Jian P; Yan WS; Chao SL; Liang P; Zhen L; Ling QB; Hong LY; Ping LY; Jian W; Fang JM; Ling L; Dong WX; Ming ZX; Jian N
J Pediatr Hematol Oncol; 2012 Jan; 34(1):43-6. PubMed ID: 22052167
[TBL] [Abstract][Full Text] [Related]
8. Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.
Xiao YH; Li XH; Tan T; Liang T; Yi H; Li MY; Zeng GQ; Wan XX; Qu JQ; He QY; Li JH; Chen Y; Xiao ZQ
J Cancer Res Clin Oncol; 2011 Dec; 137(12):1831-40. PubMed ID: 21922325
[TBL] [Abstract][Full Text] [Related]
9. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of the alternative Wilms tumor gene overexpression-hypermethylation signature in acute myeloid leukemia.
El Bordiny M; Al-Ghandour A; Abo Elwafa RA; Fayed O
Clin Transl Oncol; 2019 Jul; 21(7):864-873. PubMed ID: 30506133
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.
Röhrs S; Dirks WG; Meyer C; Marschalek R; Scherr M; Slany R; Wallace A; Drexler HG; Quentmeier H
Mol Cancer; 2009 Oct; 8():86. PubMed ID: 19835597
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.
Wagner M; Schmelz K; Dörken B; Tamm I
Leuk Res; 2008 Jul; 32(7):1054-60. PubMed ID: 18206228
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
15. SMG1 acts as a novel potential tumor suppressor with epigenetic inactivation in acute myeloid leukemia.
Du Y; Lu F; Li P; Ye J; Ji M; Ma D; Ji C
Int J Mol Sci; 2014 Sep; 15(9):17065-76. PubMed ID: 25257528
[TBL] [Abstract][Full Text] [Related]
16. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
[TBL] [Abstract][Full Text] [Related]
17. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas.
Peng D; Hu TL; Jiang A; Washington MK; Moskaluk CA; Schneider-Stock R; El-Rifai W
PLoS One; 2011; 6(7):e22009. PubMed ID: 21818286
[TBL] [Abstract][Full Text] [Related]
18. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
[TBL] [Abstract][Full Text] [Related]
19. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
Lian XY; Ma JC; Zhou JD; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Li XX; He PF; Yan Y; Lin J; Qian J
J Cell Physiol; 2019 Jun; 234(6):9438-9446. PubMed ID: 30317626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]